Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NER1006 vs SP+MS for Bowel Cleansing (DAYB Study)
NCT02273141Phase 3Completed
- Sponsor
- Norgine
- Start
- Nov 2014
- Primary completion
- Aug 2015
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 6
01
Overview
A Phase 3 trial of polyethylene glycol + electrolytes + ascorbic acid, sponsored by Norgine. Started Nov 2014; status: completed.
02
Drugs
polyethylene glycol + electrolytes + ascorbic acid
Beyond the preview
Go deeper on NCT02273141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273141.